Cytokinetics, Incorporated

Contributing Author

Recent Articles by Cytokinetics, Incorporated

Jun-17	Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CYTK GlobeNewswire
Jun-10	Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program CYTK GlobeNewswire
May-29	Cytokinetics to Participate in the Jefferies Global Healthcare Conference CYTK GlobeNewswire
May-18	Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress CYTK GlobeNewswire
May-16	Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CYTK GlobeNewswire
May-15	Cytokinetics to Host Symposium on Contemporary Landscapes in Muscle Biology CYTK GlobeNewswire
May-13	Cytokinetics Announces Positive Topline Results From MAPLE-HCM CYTK GlobeNewswire
May-08	Cytokinetics Announces Four Upcoming Presentations at the European Society Of Cardiology Heart Failure 2025 Congress CYTK GlobeNewswire
May-07	Cytokinetics to Hold Annual Meeting of Stockholders CYTK GlobeNewswire
May-06	Cytokinetics Reports First Quarter 2025 Financial Results and Provides Business Update CYTK GlobeNewswire
May-01	Cytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy CYTK GlobeNewswire